Han Chang's Biography

Han Chang, Principal Scientist, Bristol-Myers Squibb

Dr. Han Chang is currently leading cancer genomics and nextgen sequencing efforts at Bristol-Myers Squibb Co. He has extensive experience of applying genomics technologies and bioinformatics to oncology and immunology drug discovery and development. Dr. Han Chang received Ph.D. from Harvard University and completed postdoctoral training at Stanford University.

Applications of Cancer Genomics and Nextgen Sequencing in Cancer Biomarker Research

Thursday, 19 April 2012 at 11:15

Add to Calendar ▼2012-04-19 11:15:002012-04-19 12:15:00Europe/LondonApplications of Cancer Genomics and Nextgen Sequencing in Cancer Biomarker ResearchSELECTBIOenquiries@selectbiosciences.com

Identification of alterations in the cancer genome is essential for cancer biomarker research, and nextgen sequencing technologies can provide comprehensive views of the cancer genome. I will present an example using integrated analysis of cancer genomic data to elucidate mechanisms of acquired resistance in a pre-clinical model. The impact of nextgen sequencing technologies on cancer genomics and oncology R&D will also be discussed.

Add to Calendar ▼2012-04-19 00:00:002012-04-20 00:00:00Europe/LondonGenomic BiomarkersSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors